Inventor · disambiguated record
Howard E. Greene
Also filed as: GREENE HOWARD E · GREENE JR HOWARD · GREENE JR HOWARD E
15 granted patents·6 pending applications·3,569 citations·filing 1980–2022
95Inventor score
Files withSATIOGEN PHARMACEUTICALS INC8AMYLIN PHARMACEUTICALS INC4YOUNG ANDREW A3GEDULIN BRONISLAVA2GREENE HOWARD E2
Top patents by PatentIndex Score
21 records- 0198US4486530AImmunometric assays using monoclonal antibodiesHYBRITECH INC·Filed 1981·Granted Dec 4, 1984·557 cites·33 claims
- 0298US4376110AImmunometric assays using monoclonal antibodiesHYBRITECH INC·Filed 1980·Granted Mar 8, 1983·2.7k cites·29 claims
- 0395US9339480B2Bile acid recycling inhibitors for treatment of obesity and diabetesYOUNG ANDREW A·Filed 2009·Granted May 17, 2016·38 cites·23 claims
- 0493US9656017B2Infusion delivery devices and methodsGREENE HOWARD E·Filed 2015·Granted May 23, 2017·31 cites·19 claims
- 0591US5266561ATreatment of type 2 diabetes mellitusAMYLIN PHARMACEUTICALS INC·Filed 1991·Granted Nov 30, 1993·71 cites·4 claims
- 0688US9345715B2Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereofSATIOGEN PHARMACEUTICALS INC·Filed 2012·Granted May 24, 2016·10 cites·11 claims
- 0788US8318663B2Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agentYOUNG ANDREW A·Filed 2009·Granted Nov 27, 2012·9 cites·17 claims
- 0888US5281581ATreatment of insulin resistanceAMYLIN PHARMACEUTICALS INC·Filed 1992·Granted Jan 25, 1994·49 cites·4 claims
- 0986US11260053B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2019·Granted Mar 1, 2022·1 cites·21 claims
- 1080US10555950B2Bile acid recycling inhibitors for treatment of obesity and diabetesSATIOGEN PHARMACEUTICALS INC·Filed 2016·Granted Feb 11, 2020·2 cites·6 claims
- 1180US10251880B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2014·Granted Apr 9, 2019·3 cites·12 claims
- 1279US5942227APharmaceutical compositions containing antibodies to amylinAMYLIN PHARMACEUTICALS INC·Filed 1996·Granted Aug 24, 1999·33 cites·2 claims
- 1378US10188646B2Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsGEDULIN BRONISLAVA·Filed 2012·Granted Jan 29, 2019·3 cites·15 claims
- 1477US2022362238A1Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsSATIOGEN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1573US5716619ATreatment of type 2 diabetes mellitusAMYLIN PHARMACEUTICALS INC·Filed 1994·Granted Feb 10, 1998·19 cites·8 claims
- 1654US10028952B2Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereofSATIOGEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·0 cites·19 claims
- 1754US2011294767A1Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditionsGEDULIN BRONISLAVA·Filed 2011·Application pending·0 cites
- 1853US2012157399A1Bile acid recycling inhibitors for treatment of obesity and diabetesYOUNG ANDREW A·Filed 2012·Application pending·0 cites
- 1948US2017216404A1Infusion delivery devices and methodsGREENE HOWARD E·Filed 2017·Application pending·0 cites
- 2042US2013090590A1Methods and Apparatus for Treating Obesity and DiabetesSATIOGEN PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2137US2011152204A1Treatment of Obesity or Diabetes with Bile Acid SequestrantsSATIOGEN PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Howard E. Greene files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →